In the central nervous system (CNS), EP3 inhibition abrogated the migration and proliferation of human glioblastoma cells [18], alleviated cognitive deficits in the APP/PS1 mouse model of AD [19], attenuated brain injury, and improved neurological functional recovery in ischemic stroke model of mice [20]. The gene discussed is PTGER3; the disease is ischemic stroke.